ceritinib ROS1 Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state First line ceritinib targeted therapy
crizotinib ROS1 Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state First line crizotinib targeted therapy
entrectinib ROS1 Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state First line entrectinib targeted therapy
entrectinib ROS1 Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state Subsequent line entrectinib targeted therapy
lorlatinib ROS1 Fusion Non-Small Cell Lung Carcinoma Advanced, +1 more state Subsequent line lorlatinib targeted therapy
repotrectinib ROS1 Fusion Non-Small Cell Lung Carcinoma Advanced Subsequent line repotrectinib targeted therapy